Effects of Vitamin D3 Supplementation on Cardiovascular and Cancer Outcomes by eGFR in VITAL | Zendy

Christine P. Limonte | Zendy; Leila R. Zelnick | Zendy; Andrew N. Hoofnagle | Zendy; Ravi Thadhani | Zendy; Michal L. Melamed | Zendy; Samia Mora | Zendy; Nancy R. Cook | Zendy; Heike LuttmannGibson | Zendy; Howard D. Sesso | Zendy; IMin Lee | Zendy; Julie E. Buring | Zendy; JoAnn E. Manson | Zendy; Ian H. de Boer | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effects of Vitamin D3 Supplementation on Cardiovascular and Cancer Outcomes by eGFR in VITAL

Author(s) -

Christine P. Limonte,

Leila R. Zelnick,

Andrew N. Hoofnagle,

Ravi Thadhani,

Michal L. Melamed,

Samia Mora,

Nancy R. Cook,

Heike LuttmannGibson,

Howard D. Sesso,

IMin Lee,

Julie E. Buring,

JoAnn E. Manson,

Ian H. de Boer

Publication year - 2022

Publication title -

kidney360

Language(s) - English

Resource type - Journals

ISSN - 2641-7650

DOI - 10.34067/kid.0006472022

Subject(s) - medicine , vitamin d and neurology , placebo , parathyroid hormone , vitamin , secondary hyperparathyroidism , renal function , endocrinology , cancer , vitamin d deficiency , gastroenterology , calcium , pathology , alternative medicine

Reduced 25-hydroxyvitamin D (25[OH]D) metabolism and secondary hyperparathyroidism are common with lower estimated glomerular filtration rate (eGFR) and may contribute to cardiovascular disease and cancer risk.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research